Differences in aqueous humor protein profiles in patients with proliferative diabetic retinopathy before and after aflibercept treatment.

"data availability all data generated or analysed during this study are included in this published article and its supplementary information files or via proteomexchange with identifier pxd039210."

"Declarations Ethics approval and consent to participateAll experimental protocols conformed to the tenets of the Declaration of Helsinki and were approved by Ethics Committee of Drug Clinical Trials of Beijing Union Medical College Hospital. Informed consent was obtained from all subjects and/or their legal guardian(s). Consent for publicationNot applicable. Competing interestThe authors declare that they have no competing interests. Competing interest The authors declare that they have no competing interests."

"Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors."